Historic psychedelic drug trials and the treatment of anxiety disorders
Weston, N. M., Gibbs, D., Bird, C. I., Daniel, A., Jelen, L. A., Knight, G., & Rucker, J. J. | Depression and Anxiety | 05 July 2020
Psychedelic treatment of functional neurological disorder: a systematic review
Butler, M., Seynaeve, M., Nicholson, T. R., Pick, S., Kanaan, R. A., Lees, A., ... & Rucker, J. | Therapeutic Advances in Psychopharmacology | 11 May 2020
Psychiatry & the psychedelic drugs. Past, present & future.
Rucker, J. J., Iliff, J., & Nutt, D. J. | Neuropharmacology | 25 December 2017
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
Carhart-Harris, R. L., Bolstridge, M., Day, C. M. J., Rucker, J., Watts, R., Erritzoe, D. E., ... & Rickard, J. A. | Psychopharmacology | 8 November 2017
Psilocybin with psychological support for treatment-resistant depression
Carhart-Harris, R. L., Bolstridge, M., Rucker, J., Day, C. M., Erritzoe, D., Kaelen, M., ... & Taylor, D. | The Lancet Psychiatry | 17 May 2016
Psilocybin with psychological support for treatment-resistant depression: An open-label feasibility study
Carhart-Harris, R. L., Bolstridge, M., Rucker, J., Day, C. M., Erritzoe, D., Kaelen, M., ... & Taylor, D. | The Lancet Psychiatry | 17 May 2016